Ccr6 is dispensable for the development of skin lesions induced by imiquimod despite its effect on epidermal homing of IL-22-producing cells.
(2017) The Journal of Investigative Dermatology — Vol. 137, n° 5, p. 1094-1103 (2017)
Files
CochezCCR62017.pdf
Open Access - Adobe PDF
- 1.91 MB
Details
- Authors
- Abstract
- Expression of the chemokine receptor Ccr6 is shared by most IL-22 producing cells and Ccr6-deficient mice showed decreased IL-22 production and skin inflammation upon IL-23 intradermal injections. To determine whether this observation might be extended to another psoriasis model, we applied imiquimod on Ccr6-deficient mice. Whereas epidermal IL-22 production was decreased because of a deficient recruitment of γδ T cells in these mice, they were not protected against psoriatic lesions. When primary epidermis or dermis tissue culture cells from non-treated mice were stimulated ex vivo with IL-1α/IL-2/IL-23, we observed that Ccr6 is crucial for Il22 expression from epidermal but not dermal cultures. Taking advantage of Ccr6-LacZ-knock-in mice, we showed that Ccr6 is necessary for the homing of Ccr6-positive cells, probably a γδ T cell subset, which represents the main potential IL-22 source in the epidermis. Similar results were observed in Rag1(-/-) epidermis and dermis primary cultures, where a subset of innate lymphoid cells expressing Ccr6 represents the main potential source of IL-22. Taken together, our data show that Ccr6 is not required for the development of skin lesions induced by imiquimod despite its effect on epidermal homing of IL-22 producing cells.
- Affiliations
Citations
Cochez, P., Michiels, C., Hendrickx, E., Dauguet, N., WARNIER, G., Renauld, J.-C., & Dumoutier, L. (2017). Ccr6 is dispensable for the development of skin lesions induced by imiquimod despite its effect on epidermal homing of IL-22-producing cells. The Journal of Investigative Dermatology, 137(5), 1094-1103. https://doi.org/10.1016/j.jid.2016.12.023 (Original work published 2017)